Revolution Medicines, Inc.
- Stock
- Ticker RVMD
- ISIN US76155X1000
- Nasdaq
Performance, volatility and drawdowns of Revolution Medicines, Inc. since 02/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $54,774. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −73.3% in 05/2022, measured from the peak in 02/2021. It took 45 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 0.0 | – | – | 0.0 | 0.0 | – | – | 198 |
| Gross profit | – | – | – | 0.0 | – | – | – | 197 |
| Operating income | -216 | -241 | -265 | -315 | -362 | -445 | -505 | -373 |
| EBITDA | -215 | -239 | -263 | -313 | -359 | -443 | -503 | -371 |
| Net income | -195 | -213 | -248 | -305 | -365 | -454 | -644 | -407 |
| Earnings per share | -1.13 | -1.13 | -1.31 | -1.61 | -1.89 | -2.29 | -3.06 | -1.90 |
| Balance sheet | ||||||||
| Total assets | 2,558 | 2,365 | 2,430 | 2,252 | 2,355 | 2,254 | 4,323 | 4,304 |
| Liabilities | 293 | 287 | 564 | 655 | 723 | 754 | 1,717 | 1,902 |
| Equity | 2,265 | 2,078 | 1,865 | 1,597 | 1,631 | 1,500 | 2,606 | 2,402 |
| Cash | 543 | 334 | 402 | 217 | 384 | 441 | 815 | 616 |
| Cash flow | ||||||||
| Operating cash flow | -138 | -194 | -222 | -207 | -274 | -354 | -387 | -416 |
| Capital expenditure | -1.2 | -3.3 | -7.5 | -3.3 | -1.9 | -1.5 | -2.3 | -3.7 |
| Free cash flow | -140 | -198 | -229 | -211 | -276 | -356 | -390 | -419 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +82.1%, weakest 2021 at −36.4%. 3 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | −$1.90 |
| 5 Aug 2026 | −$3.06 |
| 6 May 2026 | −$2.29 |
| 25 Feb 2026 | −$1.89 |
| 5 Nov 2025 | −$1.61 |
| 6 Aug 2025 | −$1.31 |
| 7 May 2025 | −$1.13 |
| 26 Feb 2025 | −$1.13 |
| 6 Nov 2024 | −$0.94 |
| 7 Aug 2024 | −$0.81 |
| 8 May 2024 | −$0.70 |
| 26 Feb 2024 | −$1.21 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €32bn
- Market cap in trading currency
- $34.9bn
- Enterprise value
- $31.2bn
- P/E
- –
- P/S
- –
- P/B
- 14.52
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -4.1%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$1.68bn
- Net income
- −$1.87bn
- Earnings per share
- −$9.14
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -93.6%
- Return on assets
- -43.5%
Balance sheet and cash flow
- Cash
- $3.65bn
- Cash per share
- $16.88
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 8.36
- Book value per share
- $11.10
- Operating cash flow
- −$1.43bn
- Free cash flow
- −$1.44bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 216m
- Volume
- 4.74m
- Avg. volume 3 months
- 2.17m
- Relative volume
- 2.1
Price and technicals
- Price
- $161.20
- 1 day
- +1.1%
- 52-week high
- $221.15
- 52-week low
- $69.88
- Distance to 52-week high
- −27.1%
- Distance to 52-week low
- +130.7%
- Distance to 50-day line
- −15.2%
- Distance to 200-day line
- −0.2%
- RSI (14)
- 36
- Volatility 1M
- 63.7%
Performance
- 1 week
- −6.4%
- 1 month
- −14.1%
- 3 months
- −23.8%
- 6 months
- +6.4%
- YTD
- +102.4%
- 1 year
- +128.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has RVMD performed since 02/2020?
$10,000 grew to $55,779 by 20 Nov 2026, which is +28.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is RVMD?
Volatility was 56.9% per year, measured on monthly returns. The largest decline from a peak was −73.3%, with the low in 05/2022.
How does RVMD compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.4% per year at 16.5% volatility, RVMD returned +28.9% at 56.9%. The correlation of monthly returns was 0.48; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.